Health and Healthcare

Wednesday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

DYAX CORP [DYAX] +9.51%
FERMAVIR PHARMACEUTL [FMVR.OB] +8.57%
ZIOPHARM ONCOLOGY IN [ZIOP] +7.30%
ALNYLAM PHARMACEUT [ALNY] +6.75%
GENITOPE CORPORATION [GTOP] +5.85%

Diagnostic Substances

EPICEPT CORPORATION [EPCT] +11.76%
GENELABS TECH INC [GNLB] +5.00%
DIGENE CP [DIGE] +4.09%
MONOGRAM BIOSCIENCES [MGRM] +3.51%
MYRIAD GENETICS [MYGN] +3.46%

Drug Delivery

QUIGLEY CORP THE [QGLY] +5.30%
NOVADEL PHARMA INC [NVD] +5.00%
NEKTAR THERAPEUTIC [NKTR] +3.36%
GENEREX BIOTECH CORP [GNBT] +3.30%
BIOPROGRESS PLC [BPRG] +1.81%

Drug Manufacturers

ELITE PHARMA INC [ELI] +7.85%
DUSA PHARM INC [DUSA] +4.99%
CUBIST PHARMACEUTC [CBST] +4.87%
ALLOS THERAPEUTICS [ALTH] +4.61%
ARENA PHARMACEUTIC [ARNA] +3.63%

Medical Appliances & Equipment

MEDICAL ACTION IND [MDCI] +16.22%
UROLOGIX INC [ULGX] +11.18%
MEDICALCV INC [MCVI.OB] +10.87%
REGENERATION TECH [RTIX] +10.57%
VISION SCIENCES IN [VSCI] +6.45%

Medical Instruments & Supplies

ENCISION INC [ECI] +12.58%
MILESTONE SCIENTIFIC [MLSS.OB] +10.26%
BIOMIMETIC THERAPEUT [BMTI] +7.11%
PRO-DEX INC NEW [PDEX] +7.09%
CHINA MEDICAL TECH [CMED] +6.31%

Medical Laboratories & Research

PHARM PROD DEV [PPDI] +4.17%
OSI PHARMACEUTIC [OSIP] +1.61%
AETERNA ZENTARIS [AEZS] +1.25%
ERESEARCHTECHNOLOG [ERES] +0.98%
ALLIANCE IMAGING INC [AIQ] +0.85%

http://www.biohealthinvestor.com/

Sponsored: Want to Retire Early? Here’s a Great First Step

Want retirement to come a few years earlier than you’d planned? Orare you ready to retire now, but want an extra set of eyes on your finances?

Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.

Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.